Center for Genetic Engineering and Biotechnology

The Center for Genetic Engineering and Biotechnology (Spanish: Centro de Ingeniería Genética y Biotecnología, CIGB) is a research institute in Havana, Cuba. It is responsible for creating the Abdala vaccine.[1][2][3]

Center for Genetic Engineering and Biotechnology

Offices of the CIGB
Research institute overview
FormedJuly 1, 1985 (1985-07-01)
Jurisdiction Cuba
HeadquartersAvenida 31 No. 15802, Havana, Cuba
23.0738°N 82.4523°W / 23.0738; -82.4523
Websitewww.cigb.edu.cu

The Centre developed the COVID-19 vaccine Mambisa which is in the final stages of clinical trials.[4]

See also

References
  1. "Cuba's COVID vaccine rivals BioNTech-Pfizer, Moderna". DW.COM. 2021-06-27. Retrieved 2021-06-28.
  2. "ABDALA Clinical Study - Phase III". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-03-20. Retrieved March 22, 2021.
  3. "ABDALA Clinical Study". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-01-22. Retrieved March 22, 2021.
  4. Sánchez, Liz Conde (7 April 2022). "How is Mambisa progressing on the road to authorization as an anti-COVID-19 vaccine?". en.granma.cu. Retrieved 6 May 2022.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.